Form D · Biotechnology
ViTToria Biotherapeutics, Inc.
Philadelphia, PA · CIK 0001877792
Offering snapshot reported Dec 30, 2021 · SEC filing
- Reported sold
- $8.67M Offering amount: $9.25M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2021 | Initial | $8,672,731 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-427409
Source: Form D, filed Dec 30, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leon Moulder | Director |
| Preston Noon | Executive |
| Bruce Peacock | Director, Executive |
| Nicholas Siciliano | Director |
| Geeta Vemuri | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3675 Market Street Suite 200
Philadelphia, PA, 19104
Philadelphia, PA, 19104